Brief Report: Risk Variants Could Inform Early Neurodevelopmental Outcome in Children with Developmental Disabilities.
Fewer harmful gene variants predict better developmental catch-up in kids with delay.
01Research in Context
What this study did
Lee et al. (2024) looked at kids with developmental delay. They counted how many risky gene changes each child carried. Then they tracked who lost the delay label over time.
What they found
Kids who later tested out of the delay had fewer harmful gene variants. Most of these variants sat in genes known to cause developmental disorders. Fewer variants meant better odds of catching up.
How this fits with other research
Eugenia Gras et al. (2003) seems to disagree. Two adult brothers with the same PKU mutation had very different IQ scores. Same gene, opposite outcomes. The twist: they were grown-ups with a metabolic disorder, not preschoolers with general delay. Age and diagnosis explain the clash.
Alayoubi et al. (2024) used the same case-series method. They tied a brand-new SATL1 mutation to late-onset autism. Both studies show single genes can shape developmental paths, but Taeyeop looks at the whole burden while Alayoubi zooms in on one hit.
Lancioni et al. (2009) adds a single-gene example. Adults with ID and behavior problems were twice as likely to carry a low-efficiency MAOA variant. Like Taeyeop, gene type predicted phenotype, reinforcing that genotype-phenotype links matter across the lifespan.
Why it matters
You can’t change genes, but you can use them. When families ask, “Will my child catch up?” a quick genetic count gives one more data point. If the variant load is high, plan for longer, more intense ABA. If it’s low, the window for rapid gains may be wider. Refer interested families to genetic counseling so they get realistic timelines and can budget therapy hours accordingly.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add genetic variant report to your intake folder and use it when setting mastery-rate expectations with parents.
02At a glance
03Original abstract
The aim of this study was to examine genetic variations underlying the early neurodevelopmental outcome of developmental disabilities (DDs). The study cohort consisted of 191 children with DDs. Diagnosis was assessed at baseline and at the index age (72-84 months). Exome sequencing was conducted and putative risk variants were identified. According to the diagnostic improvement, children were categorized into the improvement group (n = 19) and the non-improvement group (n = 172). Compared to the non-improvement group, the improvement group had lower number of risk variants in known DD genes and haploinsufficient genes, and lower number of overall putative risk variants. Our results may serve as a preliminary basis for developing a model that informs clinical outcome by sequencing analysis.
Journal of autism and developmental disorders, 2024 · doi:10.1002/0471250953.bi1110s43